Related Experiment Video
Updated: Jun 18, 2026

A Surgical Approach for Optic Nerve Crush in a Rabbit Model
Published on: July 8, 2025
Neuroprotection for optic nerve disorders
Anne-Caroline Bessero1, Peter G H Clarke
1Department of Neuro-Ophthalmology, The National Hospital for Neurology and Neurosurgery, London, UK. anncaroline.bessero@uclh.nhs.uk
Purpose Of Review:
The concept that optic nerve fiber loss might be reduced by neuroprotection arose in the mid 1990s. The subsequent research effort, focused mainly on rodent models, has not yet transformed into a successful clinical trial, but provides mechanistic understanding of retinal ganglion cell death and points to potential therapeutic strategies. This review highlights advances made over the last year.
Recent Findings:
In excitotoxicity and axotomy models retinal ganglion cell death has been shown to result from a complex interaction between retinal neurons and Müller glia, which release toxic molecules including tumor necrosis factor alpha. This counteracts neuroprotection by neurotrophins such as nerve growth factor, which bind to p75NTR receptors on Müller glia stimulating the toxic release. Another negative effect against neurotrophin-mediated protection involves the action of LINGO-1 at trkB brain-derived neurotrophic factor (BDNF) receptors, and BDNF neuroprotection is enhanced by an antagonist to LINGO-1. As an alternative to pharmacotherapy, retinal defences can be stimulated by exposure to infrared radiation.
Summary:
The mechanisms involved in glaucoma and other optic nerve disorders are being clarified in rodent models, focusing on retrograde degeneration following axonal damage, excitotoxicity and inflammatory/autoimmune mechanisms. Neuroprotective strategies are being refined in the light of the mechanistic understanding.
Insights
Neuroprotection research in rodent models reveals complex mechanisms of retinal ganglion cell death. Advances in understanding excitotoxicity and inflammatory pathways are refining strategies for optic nerve disorders like glaucoma.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Neuroprotection strategies for optic nerve fiber loss emerged in the 1990s.
- Research primarily utilizes rodent models to understand retinal ganglion cell death.
- Clinical translation of neuroprotective therapies remains a challenge.
Purpose of the Study:
- To review recent advances in understanding the mechanisms of optic nerve damage.
- To highlight potential therapeutic strategies for neuroprotection.
- To provide an update on the last year's progress in the field.
Main Methods:
- Review of rodent models of excitotoxicity and axotomy.
- Analysis of molecular interactions between retinal neurons and Müller glia.
- Investigation of neurotrophin signaling pathways and inflammatory mediators.
Main Results:
- Retinal ganglion cell death involves complex interactions, including Müller glia releasing tumor necrosis factor alpha.
- Neurotrophins like nerve growth factor can paradoxically stimulate toxic release via p75NTR receptors.
- LINGO-1 inhibits brain-derived neurotrophic factor (BDNF) neuroprotection; LINGO-1 antagonists enhance BDNF efficacy.
- Infrared radiation shows potential for stimulating retinal defenses.
Conclusions:
- Mechanisms of glaucoma and optic nerve disorders are increasingly understood through rodent models.
- Key mechanisms include retrograde degeneration, excitotoxicity, and inflammatory/autoimmune processes.
- Neuroprotective strategies are being refined based on enhanced mechanistic insights.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Neurogenesis and Regeneration of Nervous Tissue
